Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥972m2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥2.6bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥993m2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥56m2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥69m2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥53m2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥387m2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥88m2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥39m2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥112m2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥25m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥327m2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥76m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥25m2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥76m2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥4.4bnat 2024-09-30Cons.Assets
Total assets¥5.2bnat 2024-03-31Cons.Assets
Total assets¥4.5bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥907mat 2024-09-30Cons.Liabilities
Total liabilities¥1.5bnat 2024-03-31Cons.Liabilities
Net assets / equity¥3.5bnat 2024-09-30Cons.Net assets
Net assets / equity¥3.7bnat 2024-03-31Cons.Net assets
Net assets / equity¥3.4bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥1.8bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥2.3bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥1.7bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.3bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.0bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow−¥157m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥399m2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥174m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥247m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥89m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥40m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥154m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥146m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥140m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥18.552024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥238.992023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥55.772023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio79.6%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio70.9%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio76.2%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 24
SegmentItemPeriodValue
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue2024-04-01 → 2024-09-30¥375m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue external2024-04-01 → 2024-09-30¥375m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentsegment profit2024-04-01 → 2024-09-30¥37m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue2024-04-01 → 2024-09-30¥353m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue external2024-04-01 → 2024-09-30¥353m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentsegment profit2024-04-01 → 2024-09-30¥100m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue2024-04-01 → 2024-09-30¥244m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue external2024-04-01 → 2024-09-30¥244m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentsegment profit2024-04-01 → 2024-09-30¥70m
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥972m
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥972m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥207m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue2023-04-01 → 2023-09-30¥332m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue external2023-04-01 → 2023-09-30¥332m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentsegment profit2023-04-01 → 2023-09-30¥9m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue2023-04-01 → 2023-09-30¥345m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue external2023-04-01 → 2023-09-30¥345m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentsegment profit2023-04-01 → 2023-09-30¥103m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue2023-04-01 → 2023-09-30¥317m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue external2023-04-01 → 2023-09-30¥317m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentsegment profit2023-04-01 → 2023-09-30¥110m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥993m
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥993m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥222m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 432
ItemContextValueUnit
Foreign currency translation adjustmentPrior1YearInstant22155000JPY
Foreign currency translation adjustmentCurrentQuarterInstant16538000JPY
Valuation and translation adjustmentsPrior1YearInstant52325000JPY
Valuation and translation adjustmentsCurrentQuarterInstant35185000JPY
Net assetsPrior1YearInstant3674815000JPY
Net assetsCurrentQuarterInstant3532401000JPY
Liabilities and net assetsPrior1YearInstant5182742000JPY
Liabilities and net assetsCurrentQuarterInstant4439217000JPY
Net salesPrior1YTDDuration993420000JPY
Net salesCurrentYTDDuration971509000JPY
Cost of salesPrior1YTDDuration604422000JPY
Cost of salesCurrentYTDDuration623496000JPY
Gross profitPrior1YTDDuration388998000JPY
Gross profitCurrentYTDDuration348012000JPY
Selling general and administrative expensesPrior1YTDDuration319723000JPY
Selling general and administrative expensesCurrentYTDDuration292393000JPY
Operating incomePrior1YTDDuration69275000JPY
Operating incomeCurrentYTDDuration55618000JPY
Interest income noiPrior1YTDDuration1299000JPY
Interest income noiCurrentYTDDuration2878000JPY
Dividends income noiPrior1YTDDuration1544000JPY
Dividends income noiCurrentYTDDuration1583000JPY
Foreign exchange gains noiPrior1YTDDuration9453000JPY
Foreign exchange gains noiCurrentYTDDuration-JPY
Electricity sale income noiPrior1YTDDuration7005000JPY
Electricity sale income noiCurrentYTDDuration6517000JPY
Other noiPrior1YTDDuration3061000JPY
Other noiCurrentYTDDuration1858000JPY
Non operating incomePrior1YTDDuration22363000JPY
Non operating incomeCurrentYTDDuration12837000JPY
Interest expenses noePrior1YTDDuration133000JPY
Interest expenses noeCurrentYTDDuration70000JPY
Foreign exchange losses noePrior1YTDDuration-JPY
Foreign exchange losses noeCurrentYTDDuration12319000JPY
Electricity sale expenses noePrior1YTDDuration3130000JPY
Electricity sale expenses noeCurrentYTDDuration2724000JPY
Non operating expensesPrior1YTDDuration3263000JPY
Non operating expensesCurrentYTDDuration15115000JPY
Ordinary incomePrior1YTDDuration88375000JPY
Ordinary incomeCurrentYTDDuration53340000JPY
Surrender value of insurance eiPrior1YTDDuration24026000JPY
Surrender value of insurance eiCurrentYTDDuration-JPY
Extraordinary incomePrior1YTDDuration24026000JPY
Extraordinary incomeCurrentYTDDuration-JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration0JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration14027000JPY
Extraordinary lossPrior1YTDDuration0JPY
Extraordinary lossCurrentYTDDuration14027000JPY
Income before income taxesPrior1YTDDuration112401000JPY
Income before income taxesCurrentYTDDuration39313000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass